New technology ends swivel-chair effect, reduces friction, frees time to focus on patients

新技术结束了转椅效应，减少了摩擦，腾出时间专注于患者

COLUMBIA, Md., Feb. 12, 2024 /PRNewswire/ -- Advarra, the market leader in regulatory review solutions and clinical research technology for sites and sponsors, announces single sign-on technology for clinical trial sites to reduce friction, increase security and free time to focus on patients. Advarra's new single sign-on (SSO) capabilities empower site staff to use their own site-sanctioned credentials to access key systems including sponsor-provided technology.

哥伦比亚，马里兰州，2024年2月12日/PRNewswire/--Advarra是网站和赞助商监管审查解决方案和临床研究技术的市场领导者，宣布为临床试验网站提供单一登录技术，以减少摩擦，增加安全性和专注于患者的自由时间。Advarra的新单点登录（SSO）功能使站点工作人员能够使用自己的站点认可凭据访问关键系统，包括赞助商提供的技术。

An industry-first, Advarra SSO delivers a sought-after process simplification crucial to sites, especially as the number of trial technologies continues to grow..

作为行业首创，Advarra SSO提供了备受追捧的流程简化，这对站点至关重要，尤其是随着试用技术数量的不断增长。。

According to a 2023 Study Activation Survey, six in 10 sites are managing more technology than five years ago with nearly 70% reporting six or more logins per study and some reporting as many as 20 logins per study. To address this complexity, 81% say using their own site credentials to access various systems would be valuable.

根据2023年的一项研究激活调查，与五年前相比，十分之六的网站管理的技术更多，近70%的网站报告每次研究登录六次或更多，有些网站报告每次研究登录多达20次。为了解决这种复杂性，81%的人表示，使用自己的站点凭据访问各种系统将是有价值的。

Advarra's site technology already enables SSO within Advarra's ecosystem, and now allows sites to access Advarra's industry-leading Longboat technology with their own credentials. Longboat connects all clinical research stakeholders – sites, sponsors, and patients – to centralize and simplify trials and deliver a better clinical research experience for all..

Advarra的站点技术已经能够在Advarra的生态系统中实现SSO，现在允许站点使用自己的凭据访问Advarra业界领先的长艇技术。Longboat将所有临床研究利益相关者（站点、赞助商和患者）联系起来，以集中和简化试验，并为所有人提供更好的临床研究体验。。

'Large academic medical centers are conducting hundreds of trials for dozens of different sponsors, and this comes with a myriad of systems each with individual login credentials. Many staff require spreadsheets just to keep track of all their different passwords,' explained Brian Sevier, PhD, chief operating officer at Yale Center for Clinical Investigation.

“大型学术医疗中心正在为数十个不同的赞助商进行数百次试验，这伴随着无数的系统，每个系统都有个人的登录凭据。耶鲁大学临床调查中心首席运营官布莱恩·塞维尔博士解释说，许多员工需要电子表格来记录他们所有不同的密码。

'Not only does this complexity burden staff and slow trials, but it can also be a security issue such as when working with temporary consultants. With secure single sign-on, it's easy to comprehensively remove all system access at the end of a contract or trial. This is a breakthrough in site technology.'.

“这种复杂性不仅给工作人员带来负担，而且审判速度缓慢，而且还可能是一个安全问题，例如与临时顾问合作时。有了安全的单点登录，很容易在合同或试用结束时全面删除所有系统访问权限。这是现场技术的突破。”。

With one click, site teams can provide varying levels of secure access or completely lock out access to all commonly used systems in a trial. Advarra's SSO capability also eliminates endless password juggling and swiveling back and forth between applications – even screens – to save time and free staff to focus on patient care..

只需单击一下，站点团队就可以提供不同级别的安全访问，或者在试验中完全锁定对所有常用系统的访问。Advarra的SSO功能还消除了在应用程序（甚至屏幕）之间无休止的密码切换和来回旋转，从而节省了时间，并使员工能够专注于患者护理。。

'Reducing the number of clinical systems and logins used by sites is key to decreasing operational friction, but merely providing sites with a unified login for just one provider's technology is insufficient,' explained Elisa Cascade, Chief Product Officer at Advarra. 'SSO technology that enlists a site's own credentials is the next big step in reaching our broader vision for a fully connected clinical trial ecosystem that prioritizes a streamlined user experience for operational efficiency, improved trial execution, and compliance.'.

Advarra首席产品官Elisa Cascade解释说：“减少网站使用的临床系统和登录数量是减少运营摩擦的关键，但仅仅为网站提供一个提供商技术的统一登录是不够的。”SSO技术可以获得网站自己的认证，这是实现我们对完全连接的临床试验生态系统的更广泛愿景的下一个重要步骤，该生态系统优先考虑简化的用户体验，以提高操作效率，改进试验执行和法规遵从性。”。

Advarra SSO capability is already available for Advarra site technology, and will be available within Advarra Longboat in early 2024.

Advarra SSO功能已可用于Advarra site technology，并将于2024年初在Advarra Longboat中提供。

Additional Information• Learn more about Advarra's site-specific clinical trial technology: www.advarra.com/solutions-for/clinical-trial-sites/ • Connect with Advarra on LinkedIn: linkedin.com/company/advarra

其他信息•了解有关Advarra网站特定临床试验技术的更多信息：www.Advarra.com/solutions-for/clinical-trial-sites/•在LinkedIn上与Advarra联系：LinkedIn.com/company/Advarra

About AdvarraAdvarra breaks the silos that impede clinical research, aligning patients, sites, sponsors, and CROs in a connected ecosystem to accelerate trials. Advarra is number one in research review services, site and sponsor technology, and clinical trial experience software, and is trusted by the top 50 global biopharma sponsors, top 20 CROs, and 50,000 site investigators worldwide.

关于AdvarraAdvarra打破了阻碍临床研究的孤岛，在一个相互关联的生态系统中调整患者、网站、赞助商和CRO，以加速试验。Advarra在研究审查服务、网站和赞助商技术以及临床试验体验软件方面排名第一，并受到全球50强生物制药赞助商、20强CRO和50000名网站调查人员的信任。

Advarra solutions enable collaboration, transparency, and speed needed to optimize trial operations, ensure patient safety and engagement, and reimagine clinical research while improving compliance. For more information, visit advarra.com..

Advarra解决方案能够实现优化试验操作所需的协作、透明度和速度，确保患者安全和参与度，并在提高依从性的同时重新规划临床研究。有关更多信息，请访问advarra.com。。

SOURCE Advarra

来源Advarra